Insider · CIK 0001485088

Last Andrew J.

Reports to the SEC for 4 companies · NASHVILLE, TN

sec.gov

Transactions

Companies

Filings

CIK

0001485088

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-01	IMDXInsight Molecular Diagnostics Inc.F Tax Payment	Director	FTax Payment	−7,700 sh	$5.69	−$43.8K	58,752
2026-06-11	IMDXInsight Molecular Diagnostics Inc.A Award	Director	AAward	+26.9K sh	—	—	66,452
2025-07-01	IMDXInsight Molecular Diagnostics Inc.A Award	Director	AAward	+35K sh	—	—	39,509
2024-09-06	BIOBIO-RAD LABORATORIES, INC.M Exercise/Conversion	EVP, Chief Operating Officer	MExercise/Conversion	+3,000 sh	$299.24	+$898K	10,559.45
2024-09-06	BIOBIO-RAD LABORATORIES, INC.S Sale	EVP, Chief Operating Officer	SSale	−3,000 sh	$329.94	−$990K	7,559.45
2024-09-06	BIOBIO-RAD LABORATORIES, INC. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	EVP, Chief Operating Officer	MExercise/Conversion	−3,000 sh	—	—	0
2024-09-02	BIOBIO-RAD LABORATORIES, INC.M Exercise/Conversion	EVP, Chief Operating Officer	MExercise/Conversion	+903 sh	—	—	8,017.45
2024-09-02	BIOBIO-RAD LABORATORIES, INC.F Tax Payment	EVP, Chief Operating Officer	FTax Payment	−458 sh	$337.32	−$154K	7,559.45
2024-09-02	BIOBIO-RAD LABORATORIES, INC. · Restricted Stock UnitsM Exercise/Conversion	EVP, Chief Operating Officer	MExercise/Conversion	−903 sh	—	—	0
2024-09-01	BIOBIO-RAD LABORATORIES, INC.M Exercise/Conversion	EVP, Chief Operating Officer	MExercise/Conversion	+1,252 sh	—	—	7,010.45
2024-09-01	BIOBIO-RAD LABORATORIES, INC.F Tax Payment	EVP, Chief Operating Officer	FTax Payment	−635 sh	$337.32	−$214K	6,375.45
2024-09-01	BIOBIO-RAD LABORATORIES, INC.M Exercise/Conversion	EVP, Chief Operating Officer	MExercise/Conversion	+867 sh	—	—	7,242.45
2024-09-01	BIOBIO-RAD LABORATORIES, INC.F Tax Payment	EVP, Chief Operating Officer	FTax Payment	−440 sh	$337.32	−$148K	6,802.45
2024-09-01	BIOBIO-RAD LABORATORIES, INC.M Exercise/Conversion	EVP, Chief Operating Officer	MExercise/Conversion	+633 sh	—	—	7,435.45
2024-09-01	BIOBIO-RAD LABORATORIES, INC.F Tax Payment	EVP, Chief Operating Officer	FTax Payment	−321 sh	$337.32	−$108K	7,114.45
2024-09-01	BIOBIO-RAD LABORATORIES, INC. · Restricted Stock UnitsM Exercise/Conversion	EVP, Chief Operating Officer	MExercise/Conversion	−1,252 sh	—	—	3,756
2024-09-01	BIOBIO-RAD LABORATORIES, INC. · Restricted Stock UnitsM Exercise/Conversion	EVP, Chief Operating Officer	MExercise/Conversion	−867 sh	—	—	1,735
2024-09-01	BIOBIO-RAD LABORATORIES, INC. · Restricted Stock UnitsM Exercise/Conversion	EVP, Chief Operating Officer	MExercise/Conversion	−633 sh	—	—	633
2024-07-01	IMDXInsight Molecular Diagnostics Inc. · Option to Purchase Common StockA Award	Director	AAward	+30K sh	—	—	30,000
2024-04-29	BIOBIO-RAD LABORATORIES, INC.M Exercise/Conversion	EVP, Chief Operating Officer	MExercise/Conversion	+1,000 sh	—	—	6,076.888
2024-04-29	BIOBIO-RAD LABORATORIES, INC.F Tax Payment	EVP, Chief Operating Officer	FTax Payment	−357 sh	$277.11	−$98.9K	5,719.888
2024-04-29	BIOBIO-RAD LABORATORIES, INC. · Restricted Stock UnitsM Exercise/Conversion	EVP, Chief Operating Officer	MExercise/Conversion	−1,000 sh	—	—	0
2024-03-08	BIOBIO-RAD LABORATORIES, INC. · Non-Qualified Stock Option (right to buy)A Award	EVP, Chief Operating Officer	AAward	+5,891 sh	—	—	5,891
2023-09-02	BIOBIO-RAD LABORATORIES, INC.M Exercise/Conversion	EVP, Chief Operating Officer	MExercise/Conversion	+903 sh	—	—	5,487.6
2023-09-02	BIOBIO-RAD LABORATORIES, INC.F Tax Payment	EVP, Chief Operating Officer	FTax Payment	−448 sh	$394.60	−$177K	5,039.6
2023-09-02	BIOBIO-RAD LABORATORIES, INC. · Restricted Stock UnitsM Exercise/Conversion	EVP, Chief Operating Officer	MExercise/Conversion	−903 sh	—	—	903
2023-09-01	BIOBIO-RAD LABORATORIES, INC.M Exercise/Conversion	EVP, Chief Operating Officer	MExercise/Conversion	+867 sh	—	—	4,660.6
2023-09-01	BIOBIO-RAD LABORATORIES, INC.F Tax Payment	EVP, Chief Operating Officer	FTax Payment	−430 sh	$394.60	−$170K	4,230.6
2023-09-01	BIOBIO-RAD LABORATORIES, INC.M Exercise/Conversion	EVP, Chief Operating Officer	MExercise/Conversion	+633 sh	—	—	4,863.6
2023-09-01	BIOBIO-RAD LABORATORIES, INC.F Tax Payment	EVP, Chief Operating Officer	FTax Payment	−279 sh	$394.60	−$110K	4,584.6
2023-09-01	BIOBIO-RAD LABORATORIES, INC. · Restricted Stock UnitsA Award	EVP, Chief Operating Officer	AAward	+5,008 sh	—	—	5,008
2023-09-01	BIOBIO-RAD LABORATORIES, INC. · Restricted Stock UnitsM Exercise/Conversion	EVP, Chief Operating Officer	MExercise/Conversion	−867 sh	—	—	2,602
2023-09-01	BIOBIO-RAD LABORATORIES, INC. · Restricted Stock UnitsM Exercise/Conversion	EVP, Chief Operating Officer	MExercise/Conversion	−633 sh	—	—	1,266
2023-06-23	IMDXInsight Molecular Diagnostics Inc.A Award	Director	AAward	+20K sh	—	—	90,170
2023-06-23	IMDXInsight Molecular Diagnostics Inc. · Option to Purchase Common StockA Award	Director	AAward	+90K sh	—	—	90,000
2023-04-29	BIOBIO-RAD LABORATORIES, INC.M Exercise/Conversion	EVP, Chief Operating Officer	MExercise/Conversion	+1,000 sh	—	—	4,112.615
2023-04-29	BIOBIO-RAD LABORATORIES, INC.F Tax Payment	EVP, Chief Operating Officer	FTax Payment	−346 sh	$450.79	−$156K	3,766.615
2023-04-29	BIOBIO-RAD LABORATORIES, INC. · Restricted Stock UnitsM Exercise/Conversion	EVP, Chief Operating Officer	MExercise/Conversion	−1,000 sh	—	—	1,000
2022-09-02	BIOBIO-RAD LABORATORIES, INC.M Exercise/Conversion	EVP, Chief Operating Officer	MExercise/Conversion	+902 sh	—	—	3,531.009
2022-09-02	BIOBIO-RAD LABORATORIES, INC.F Tax Payment	EVP, Chief Operating Officer	FTax Payment	−448 sh	$478.32	−$214K	3,083.009
2022-09-02	BIOBIO-RAD LABORATORIES, INC. · Restricted Stock UnitsM Exercise/Conversion	EVP, Chief Operating Officer	MExercise/Conversion	−902 sh	—	—	1,806
2022-09-01	BIOBIO-RAD LABORATORIES, INC.M Exercise/Conversion	EVP, Chief Operating Officer	MExercise/Conversion	+633 sh	—	—	2,943.009
2022-09-01	BIOBIO-RAD LABORATORIES, INC.F Tax Payment	EVP, Chief Operating Officer	FTax Payment	−314 sh	$486.25	−$153K	2,629.009
2022-09-01	BIOBIO-RAD LABORATORIES, INC. · Restricted Stock UnitsA Award	EVP, Chief Operating Officer	AAward	+3,469 sh	—	—	3,469
2022-09-01	BIOBIO-RAD LABORATORIES, INC. · Restricted Stock UnitsM Exercise/Conversion	EVP, Chief Operating Officer	MExercise/Conversion	−633 sh	—	—	1,899
2022-08-17	IMDXInsight Molecular Diagnostics Inc.P Purchase	Director	PPurchase	+20K sh	$0.87	+$17.4K	70,170
2022-08-15	IMDXInsight Molecular Diagnostics Inc.A Award	Director	AAward	+10K sh	—	—	50,170
2022-08-15	IMDXInsight Molecular Diagnostics Inc. · Option to Purchase Common StockA Award	Director	AAward	+45K sh	—	—	45,000
2022-06-24	IMDXInsight Molecular Diagnostics Inc.M Exercise/Conversion	Director	MExercise/Conversion	+10K sh	—	—	40,170
2022-06-24	IMDXInsight Molecular Diagnostics Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	0

Recent filings

Accepted (ET)
Jul 64
Last Andrew J.0001493152-26-032233
SEC(opens sec.gov)
Jun 154
Last Andrew J.0001493152-26-028754
SEC(opens sec.gov)
Jul 34
Last Andrew J.0001641172-25-017787
SEC(opens sec.gov)
Sep 104
Last Andrew J.0001062993-24-016386
SEC(opens sec.gov)
Sep 44
Last Andrew J.0001062993-24-016169
SEC(opens sec.gov)
Jul 34
Last Andrew J.0001493152-24-026273
SEC(opens sec.gov)
Apr 304
Last Andrew J.0001062993-24-009082
SEC(opens sec.gov)

Companies

Address

C/O INSIGHT MOLECULAR DIAGNOSTICS INC. 2 INTERNATIONAL PLAZA, SUITE 510

NASHVILLE, TN, 37217